Venkata Ravi Kumar Angirekula

Venkata Ravi Kumar Angirekula practices at Ascension St. John Medical Center in Tulsa, Oklahoma, part of Ascension Health Alliance.

Venkata Ravi Kumar Angirekula's NPI, 1295020055, was assigned on June 9, 2011. Venkata Ravi Kumar Angirekula holds Maryland license P26485.

Venkata Ravi Kumar Angirekula's primary practice is Ascension St. John Medical Center, at 1923 South Utica Avenue, Tulsa, OK 74104 in Tulsa County. The practice phone is (918) 744-2296.

Venkata Ravi Kumar Angirekula's primary practice is Ascension St. John Medical Center in Tulsa, Oklahoma, part of Ascension Health Alliance. Venkata Ravi Kumar Angirekula is also affiliated with Bayhealth Hospital, Kent Campus. The medical group on file is US Acute Care Solutions. Dmand AI also links Venkata Ravi Kumar Angirekula to 3 more hospitals, 2 medical groups and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Venkata Ravi Kumar Angirekula practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Venkata Ravi Kumar Angirekula's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Venkata Ravi Kumar Angirekula is licensed in Maryland.

CMS data shows 487 Medicare services from Venkata Ravi Kumar Angirekula across 7 procedure codes in 2024, for 170 Medicare patients. Medicare paid $54,934 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 170 Medicare patients who saw Venkata Ravi Kumar Angirekula in 2024. The largest group is 75 to 84, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Venkata Ravi Kumar Angirekula's median patient age at 66, with 32% women.

In 2017, Venkata Ravi Kumar Angirekula wrote 166 Medicare Part D claims. They cover 7 drugs, with $36,945 in total drug cost. In 2016, CMS named 207 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Venkata Ravi Kumar Angirekula for performance year 2024, reported as part of a group. Venkata Ravi Kumar Angirekula accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Venkata Ravi Kumar Angirekula as offering telehealth.

CMS Open Payments shows 17 general payments to Venkata Ravi Kumar Angirekula from 10 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $142.